SUMKNDV1DERFL wrote: SoCalcalm wrote: Good morning all longs. Thanks for your questions and most of them right on point. I will put them in order of importance and be ready when Dr. Sen calls. I will report back to all of you when this happens. It could be today it could be a week or two. But I'm certain it will happen. Best regards to all longs. S
Excellent networking SoCal. Great questions everyone.
Just a comment and small additions to Chuck’s list. Among other topics, I am curious as to how they will move forward without an HC licence to process cannabis.
My questions are:
Does the transition involving the sale of THR with HC licensing move $PR into a position of simply licensing the APP process?
Just to clarify, by APP licensing, I am referring to allowing LP’s to self process cannabis and produce their own batches of Infuz20 and BNO utilizing the APP method within their privately licenced facilities.
If so, would $PR be supplying/selling the re-agents and manufacturing them from the Scarborough facility?
If leasing/selling licensing for the APP and providing the re-agents is the direction $PR is taking, will this be a long or short term strategy and will there be any considerations leading $PR to eventually produce beverages and edibles of their own? IE: Trade marks Lift/Hover.
If so, is there a time line for this new strategy/plan of business?
If Dr Sen could pls provide details on the MH JV. IE:
More specifically, obstacles they have encountered and the obstacles that remain. Are the obstacles/challenges that remain realistically attainable given the current position of $PR to move forward and establish a partnership within a reasonable time frame. If so, what is the strategy going forward with regards to MH(Licence APP as mentioned above) and time lines to finalize a deal.
Has $PR received any further interests from other companies regarding the sale of APP, Infuz20, and or BNO?
Is Dr Sen entertaining the possibilities of selling/buying $PR out right?
Finances:
As per previously posted questions:
What is the strategy for tackling the debts due in October?
Where does Dr Sen anticipate this new translational strategy will lead $PR and what does he envision for $PR in the short and long term?
Patent:
What is the status of finalizing any parts of the patent and or its entirety?
What additions, if any, have been added to the patent?
Can and or will $PR move forward in a patent pending status?
Thanks again SoCal,
Sum